Inhibition effect of epigallocatechin-3-gallate on the pharmacokinetics of calcineurin inhibitors, tacrolimus, and cyclosporine A, in rats

References

• Butt MS, Ahmad RS, Sultan MT, et al. Green tea and anticancer perspectives: updates from last decade. Crit Rev Food Sci. 2014;55:792–805.
   Web of Science ®Google Scholar
• Yiannakopoulou EC. Interaction of green tea catechins with breast cancer endocrine treatment: a systematic review. Pharmacology. 2014;94(5–6):245–248.
   PubMed Web of Science ®Google Scholar
• Oz HS, Ebersole JL. Green tea polyphenols mediated apoptosis in intestinal epithelial cells by a fad-dependent pathway. J Cancer Ther. 2010;1(3):105–113.
   PubMedGoogle Scholar
• Liu X, Shen B, Du P, et al. Transcriptomic analysis of the response of Pseudomonas fluorescens to epigallocatechin gallate by RNA-seq. Plos One. 2017;12:e177938.
   Web of Science ®Google Scholar
• Relja B, Tottel E, Breig L, et al. Effects of green tea catechins on the pro-inflammatory response after haemorrhage/resuscitation in rats. Br J Nutr. 2011;105:1791–1797.
   PubMed Web of Science ®Google Scholar
• Di Paola R, Mazzon E, Muia C, et al. Green tea polyphenol extract attenuates lung injury in experimental model of carrageenan-induced pleurisy in mice. Respir Res. 2005;6(1):66.
   PubMedGoogle Scholar
• Graham HN. Green tea composition, consumption, and polyphenol chemistry. Prev Med. 1992;21(3):334–350.
   PubMed Web of Science ®Google Scholar
• Yang CS, Hong J. Prevention of chronic diseases by tea: possible mechanisms and human relevance. Annu Rev Nutr. 2013;33(1):161–181.
   PubMedGoogle Scholar
• Misaka S, Kawabe K, Onoue S, et al. Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A activities in human liver and intestinal microsomes. Drug Metab Pharmacokinet. 2013;28(3):244–249.
   PubMed Web of Science ®Google Scholar
• Satoh T, Fujisawa H, Nakamura A, et al. Inhibitory effects of eight green tea catechins on cytochrome P450 1A2, 2C9, 2D6, and 3A4 activities. J Pharm Pharm Sci. 2016;19(2):188–197.
   PubMed Web of Science ®Google Scholar
• Muto S, Fujita K, Yamazaki Y, et al. Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Mutat Res. 2001;479(1–2):197–206.
   PubMed Web of Science ®Google Scholar
• Mohamed MF, Tseng T, Frye RF. Inhibitory effects of commonly used herbal extracts on UGT1A1 enzyme activity. Xenobiotica. 2010;40:663–669.
   PubMed Web of Science ®Google Scholar
• Jodoin J, Demeule M, Beliveau R. Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols. Biochim Biophys Acta. 2002;1542(1–3):149–159.
   PubMed Web of Science ®Google Scholar
• Fuchikami H, Satoh H, Tsujimoto M, et al. Effects of herbal extracts on the function of human organic anion-transporting polypeptide OATP-B. Drug Metab Dispos. 2006;34(4):577–582.
   PubMed Web of Science ®Google Scholar
• Wang X, Wolkoff AW, Morris ME. Flavonoids as a novel class of human organic anion-transporting polypeptide OATP1B1 (OATP-C) modulators. Drug Metab Dispos. 2005;33(11):1666–1672.
   PubMed Web of Science ®Google Scholar
• Roth M, Timmermann BN, Hagenbuch B. Interactions of green tea catechins with organic anion-transporting polypeptides. Drug Metab Dispos. 2011;39(5):920–926.
   PubMed Web of Science ®Google Scholar
• Knop J, Misaka S, Singer K, et al. Inhibitory effects of green tea and (-)-epigallocatechin gallate on transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-glycoprotein. Plos One. 2015;10(10):e139370.
   Web of Science ®Google Scholar
• Yu CP, Lin HJ, Lin SP, et al. Rhubarb decreased the systemic exposure of cyclosporine, a probe substrate of P-glycoprotein and CYP 3A. Xenobiotica. 2016;46(8):677–682.
   PubMed Web of Science ®Google Scholar
• Staatz CE, Tett SE. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet. 2004;43:623–653.
   PubMed Web of Science ®Google Scholar
• Jeong H, Chiou WL. Role of P-glycoprotein in the hepatic metabolism of tacrolimus. Xenobiotica. 2006;36(1):1–13.
   PubMed Web of Science ®Google Scholar
• Dupuis R, Yuen A, Innocenti F. The influence of UGT polymorphisms as biomarkers in solid organ transplantation. Clin Chim Acta. 2012;413:1318–1325.
   PubMed Web of Science ®Google Scholar
• Iwasaki K. Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics. Drug Metab Pharmacokinet. 2007;22(5):328–335.
   PubMed Web of Science ®Google Scholar
• Mahler N, Freyer M, Kauschke R, et al. Kidney-specific deletion of multidrug resistance-related protein 2 does not aggravate acute cyclosporine A nephrotoxicity in rats. Pharmacogenet Genomics. 2012;22(6):408–420.
   PubMed Web of Science ®Google Scholar
• Chung JH, Choi DH, Choi JS. Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats. Biopharm Drug Dispos. 2009;30(2):90–93.
   PubMed Web of Science ®Google Scholar
• Li C, Choi JS. Effects of epigallocatechin gallate on the bioavailability and pharmacokinetics of diltiazem in rats. Pharmazie. 2008;63:815–818.
   PubMed Web of Science ®Google Scholar
• Shin SC, Choi JS. Effects of epigallocatechin gallate on the oral bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats. Anticancer Drugs. 2009;20(7):584–588.
   PubMed Web of Science ®Google Scholar
• Yang W, Zhang Q, Yang Y, et al. Epigallocatechin-3-gallate decreases the transport and metabolism of simvastatin in rats. Xenobiotica. 2017;47(1):86–92.
   PubMed Web of Science ®Google Scholar
• Back JH, Ryu HH, Hong R, et al. Antiproteinuric effects of green tea extract on tacrolimus-induced nephrotoxicity in mice. Transplant Proc. 2015;47(6):2032–2034.
   PubMed Web of Science ®Google Scholar
• Mohamadin AM, El-Beshbishy HA, El-Mahdy MA. Green tea extract attenuates cyclosporine A-induced oxidative stress in rats. Pharmacol Res. 2005;51(1):51–57.
   PubMed Web of Science ®Google Scholar
• Shi SH, Zheng SS, Jia CK, et al. Inhibitory effect of tea polyphenols on transforming growth factor-beta1 expression in rat with cyclosporine A-induced chronic nephrotoxicity. Acta Pharmacol Sin. 2004;25:98–103.
   PubMed Web of Science ®Google Scholar
• Hisamura F, Kojima-Yuasa A, Kennedy DO, et al. Protective effect of green tea extract and tea polyphenols against FK506-induced cytotoxicity in renal cells. Basic Clin Pharmacol Toxicol. 2006;98(2):192–196.
   PubMed Web of Science ®Google Scholar
• Yang T, Liu Y, Huang X, et al. Quercetin3ObetaDglucoside decreases the bioavailability of cyclosporin A through regulation of drug metabolizing enzymes, transporters and nuclear receptors in rats. Mol Med Rep. 2018;18:2599–2612.
   PubMed Web of Science ®Google Scholar
• Abe O, Ono T, Sato H, et al. Role of (-)-epigallocatechin gallate in the pharmacokinetic interaction between nadolol and green tea in healthy volunteers. Eur J Clin Pharmacol. 2018;74(6):775–783. .
   PubMed Web of Science ®Google Scholar
• Han X, Zhang H, Hao H, et al. 34 effect of epigallocatechin-3-gallate on the pharmacokinetics of amlodipine in rats. Xenobiotica. 2019;49(8):970–974.
   Google Scholar
• Liu Y, Zhang D, Wang Y, et al. Study on the pharmacokinetics of deoxyschizandrin and schizandrin in combination with epigallocatechin gallate, a component of green tea, in rats. Xenobiotica. 2018;48(4):412–421.
   PubMed Web of Science ®Google Scholar
• Li X, Yu C, Guo Y, et al. Tea consumption and risk of ischaemic heart disease. Heart. 2017;103(10):783–789. .
   PubMed Web of Science ®Google Scholar
• Kim T, Ha N, Kim Y, et al. Effect of epigallocatechin-3-gallate, major ingredient of green tea, on the pharmacokinetics of rosuvastatin in healthy volunteers. Drug Des Devel Ther. 2017;11:1409–1416.
   PubMed Web of Science ®Google Scholar
• Ogasawara K, Chitnis SD, Gohh RY, et al. Multidrug resistance-associated protein 2 (MRP2/ABCC2) haplotypes significantly affect the pharmacokinetics of tacrolimus in kidney transplant recipients. Clin Pharmacokinet. 2013;52(9):751–762.
   PubMed Web of Science ®Google Scholar
• Tron C, Lemaitre F, Verstuyft C, et al. Pharmacogenetics of membrane transporters of tacrolimus in solid organ transplantation. Clin Pharmacokinet. 2019;58:593–613.
   PubMed Web of Science ®Google Scholar
• Oketch-Rabah HA, Roe AL, Rider CV, et al. United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts. Toxicol Rep. Published 2020 Feb 15 2020;7: 386–402.
   PubMed Web of Science ®Google Scholar
• Teschke R, Zhu Y, Jing J. Herb-induced liver injury in asia and current role of RUCAM for causality assessment in 11,160 published cases. J Clin Transl Hepatol. 2020;8(2):200–214.
   PubMed Web of Science ®Google Scholar
• Lindholm A, Henricsson S, Dahlqvist R. The effect of food and bile acid administration on the relative bioavailability of cyclosporin. Br J Clin Pharmacol. 1990;29(5):541–548.
   PubMed Web of Science ®Google Scholar
• Urquhart BL, Tirona RG, Kim RB. Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs. J Clin Pharmacol. 2007;47(5):566–578.
   PubMed Web of Science ®Google Scholar
• Xie W, Yeuh MF, Radominska-Pandya A, et al. Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proc Natl Acad Sci U S A. 2003;100:4150–4155.
   PubMed Web of Science ®Google Scholar
• Gardner-Stephen D, Heydel JM, Goyal A, et al. Human PXR variants and their differential effects on the regulation of human UDP-glucuronosyltransferase gene expression. Drug Metab Dispos. 2004;32:340–347.
   PubMed Web of Science ®Google Scholar
• Huang W, Zhang J, Chua SS, et al. Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proc Natl Acad Sci U S A. 2003;100:4156–4161.
   PubMed Web of Science ®Google Scholar
• Geick A, Eichelbaum M, Burk O. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J Biol Chem. 2001;276:14581–14587.
   PubMed Web of Science ®Google Scholar
• Burk O, Arnold KA, Geick A, et al. A role for constitutive androstane receptor in the regulation of human intestinal MDR1 expression. Biol Chem. 2005;386:503–513.
   PubMed Web of Science ®Google Scholar
• Kast HR, Goodwin B, Tarr PT, et al. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem. 2002;277:2908–2915.
   PubMed Web of Science ®Google Scholar
• Li G, Lin W, Araya JJ, et al. A tea catechin, epigallocatechin-3-gallate, is a unique modulator of the farnesoid X receptor. Toxicol Appl Pharmacol. 2012;258(2):268–274.
   PubMed Web of Science ®Google Scholar
• Li X, Li S, Chen M, et al. (-)-Epigallocatechin-3-gallate (EGCG) inhibits starch digestion and improves glucose homeostasis through direct or indirect activation of PXR/CAR-mediated phase II metabolism in diabetic mice. Food Funct. 2018;9(9):4651–4663.
   PubMed Web of Science ®Google Scholar
• Ezzeldin E, Asiri YA, Iqbal M. Effects of green tea extracts on the pharmacokinetics of quetiapine in rats. Evid Based Complement Alternat Med. 2015;2015:615285.
   PubMed Web of Science ®Google Scholar
• Miyazaki N, Misaka S, Ogata H, et al. Effects of itraconazole, dexamethasone and naringin on the pharmacokinetics of nadolol in rats. Drug Metab Pharmacokinet. 2013;28(4):356–361.
   PubMed Web of Science ®Google Scholar
• Misaka S, Miyazaki N, Fukushima T, et al. Effects of green tea extract and (-)-epigallocatechin-3-gallate on pharmacokinetics of nadolol in rats. Phytomedicine. 2013;20:1247–1250.
   PubMed Web of Science ®Google Scholar
• Choi JS, Burm JP. Effects of oral epigallocatechin gallate on the pharmacokinetics of nicardipine in rats. Arch Pharm Res. 2009;32:1721–1725.
   PubMed Web of Science ®Google Scholar